EA2185
OPEN TO ACCRUAL
Pancreatic Cyst Surveillance
EA2192
OPEN TO ACCRUAL
APOLLO: PII Adjuvant Olaparib vs Placebo for Resected Pancreatic Cancer with BRCA1/2 or PALB2
NCI10366
OPEN TO ACCRUAL
A Phase 1/Randomized Phase 2 Study of M3814 w/ Hypofractionated Radiotherapy for LAPC
UW26022
OPEN TO ACCRUAL
Ph III: Chemo +/- INCB161734 for KRAS G12D-Mutated Metastatic PDAC
UW26051
OPEN TO ACCRUAL
A Phase 2 Study of VS-7375 in Patients with KRAS G12D-Mutated Pancreatic Cancer
UW26057
OPEN TO ACCRUAL
Ph3 Randomized Atebimetinib + modified Gem + nab-Pac vs. standard Gem + nab-Pac in mets PDAC